Confira os artigos sobre o tema da nossa Reunião de Outubro

Immunotherapy in Breast Cancer: Current Practice and Clinical Challenges

Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with earlystage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial

Pembrolizumab for Early Triple-Negative Breast Cancer

Neoadjuvant Treatment for Triple Negative Breast Cancer: Recent Progresses and Challenges